1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Generics Market Size by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Biological Targeted Therapy Drugs 1.2.4 Prescription Drugs 1.2.5 Chinese Patent Medicine 1.2.6 Other 1.3 Market by Application 1.3.1 Global Cancer Generics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Drug Center 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trend 2.1 Global Cancer Generics Market Perspective (2016-2027) 2.2 Global Cancer Generics Growth Trends by Regions 2.2.1 Cancer Generics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cancer Generics Historic Market Size by Regions (2016-2021) 2.2.3 Cancer Generics Forecasted Market Size by Regions (2022-2027) 2.3 Industry Trends and Growth Strategy 2.3.1 Cancer Generics Industry Trends 2.3.2 Cancer Generics Market Drivers 2.3.3 Cancer Generics Market Challenges 2.3.4 Cancer Generics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Generics Players by Market Size 3.1.1 Players Covered: Ranking by Cancer Generics Revenue 3.1.2 Global Top Cancer Generics Players by Revenue (2016-2021) 3.1.3 Global Cancer Generics Revenue Market Share by Players (2016-2021) 3.1.4 Global Cancer Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Cancer Generics Market Concentration Ratio 3.2.1 Global Cancer Generics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 5 and Top 10 Players by Cancer Generics Revenue in 2020 3.3 Cancer Generics Key Players Head office and Area Served 3.4 Key Players Cancer Generics Product Solution and Service 3.5 Date of Enter into Cancer Generics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Cancer Generics Breakdown Data by Type (2016-2027) 4.1 Global Cancer Generics Historic Market Size by Type (2016-2021) 4.2 Global Cancer Generics Forecasted Market Size by Type (2022-2027) 5 Global Cancer Generics Breakdown Data by Application (2016-2027) 5.1 Global Cancer Generics Historic Market Size by Application (2016-2021) 5.2 Cancer Generics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cancer Generics Market Size (2016-2027) 6.2 Key Cancer Generics Players Market Share in North America (2020-2021) 6.3 North America Cancer Generics Market Size by Country 6.3.1 North America Cancer Generics Sales by Country (2016-2021) 6.3.2 North America Cancer Generics Market Size Forecast by Country (2022-2027) 6.4 United States Market Size Analysis 6.4.1 United States Cancer Generics Market Size (2016-2027) 6.4.2 United States Cancer Generics Market Size by Type (2016-2027) 6.4.3 United States Cancer Generics Market Size by Application (2016-2027) 6.5 Canada Market Size Analysis 6.5.1 Canada Cancer Generics Market Size (2016-2027) 6.5.2 Canada Cancer Generics Market Size by Type (2016-2027) 6.5.3 Canada Cancer Generics Market Size by Application (2016-2027) 7 Europe 7.1 Europe Cancer Generics Market Size (2016-2027) 7.2 Key Cancer Generics Players Market Share in Europe (2020-2021) 7.3 Europe Cancer Generics Market Size by Country 7.3.1 Europe Cancer Generics Sales by Country (2016-2021) 7.3.2 Europe Cancer Generics Market Size Forecast by Country (2022-2027) 7.4 Germany Market Size Analysis 7.4.1 Germany Cancer Generics Market Size (2016-2027) 7.4.2 Germany Cancer Generics Market Size by Type (2016-2027) 7.4.3 Germany Cancer Generics Market Size by Application (2016-2027) 7.5 France Market Size Analysis 7.5.1 France Cancer Generics Market Size (2016-2027) 7.5.2 France Cancer Generics Market Size by Type (2016-2027) 7.5.3 France Cancer Generics Market Size by Application (2016-2027) 7.6 U.K. Market Size Analysis 7.6.1 U.K. Cancer Generics Market Size (2016-2027) 7.6.2 U.K. Cancer Generics Market Size by Type (2016-2027) 7.6.3 U.K. Cancer Generics Market Size by Application (2016-2027) 7.7 Italy Market Size Analysis 7.7.1 Italy Cancer Generics Market Size (2016-2027) 7.7.2 Italy Cancer Generics Market Size by Type (2016-2027) 7.7.3 Italy Cancer Generics Market Size by Application (2016-2027) 7.8 Russia Market Size Analysis 7.8.1 Russia Cancer Generics Market Size (2016-2027) 7.8.2 Russia Cancer Generics Market Size by Type (2016-2027) 7.8.3 Russia Cancer Generics Market Size by Application (2016-2027) 8 Asia-Pacific 8.1 Asia-Pacific Cancer Generics Market Size (2016-2027) 8.2 Key Cancer Generics Players Market Share in Asia-Pacific (2020-2021) 8.3 Asia-Pacific Cancer Generics Market Size by Region 8.3.1 Asia-Pacific Cancer Generics Sales by Region (2016-2021) 8.3.2 Asia-Pacific Cancer Generics Market Size Forecast by Region (2022-2027) 8.4 China Market Size Analysis 8.4.1 China Cancer Generics Market Size (2016-2027) 8.4.2 China Cancer Generics Market Size by Type (2016-2027) 8.4.3 China Cancer Generics Market Size by Application (2016-2027) 8.5 Japan Market Size Analysis 8.5.1 Japan Cancer Generics Market Size (2016-2027) 8.5.2 Japan Cancer Generics Market Size by Type (2016-2027) 8.5.3 Japan Cancer Generics Market Size by Application (2016-2027) 8.6 South Korea Market Size Analysis 8.6.1 South Korea Cancer Generics Market Size (2016-2027) 8.6.2 South Korea Cancer Generics Market Size by Type (2016-2027) 8.6.3 South Korea Cancer Generics Market Size by Application (2016-2027) 8.7 India Market Size Analysis 8.7.1 India Cancer Generics Market Size (2016-2027) 8.7.2 India Cancer Generics Market Size by Type (2016-2027) 8.7.3 India Cancer Generics Market Size by Application (2016-2027) 8.8 Australia Market Size Analysis 8.8.1 Australia Cancer Generics Market Size (2016-2027) 8.8.2 Australia Cancer Generics Market Size by Type (2016-2027) 8.8.3 Australia Cancer Generics Market Size by Application (2016-2027) 8.9 Taiwan Market Size Analysis 8.9.1 Taiwan Cancer Generics Market Size (2016-2027) 8.9.2 Taiwan Cancer Generics Market Size by Type (2016-2027) 8.9.3 Taiwan Cancer Generics Market Size by Application (2016-2027) 8.10 Indonesia Market Size Analysis 8.10.1 Indonesia Cancer Generics Market Size (2016-2027) 8.10.2 Indonesia Cancer Generics Market Size by Type (2016-2027) 8.10.3 Indonesia Cancer Generics Market Size by Application (2016-2027) 8.11 Thailand Market Size Analysis 8.11.1 Thailand Cancer Generics Market Size (2016-2027) 8.11.2 Thailand Cancer Generics Market Size by Type (2016-2027) 8.11.3 Thailand Cancer Generics Market Size by Application (2016-2027) 8.12 Malaysia Market Size Analysis 8.12.1 Malaysia Cancer Generics Market Size (2016-2027) 8.12.2 Malaysia Cancer Generics Market Size by Type (2016-2027) 8.12.3 Malaysia Cancer Generics Market Size by Application (2016-2027) 9 Latin America 9.1 Latin America Cancer Generics Market Size (2016-2027) 9.2 Key Cancer Generics Players Market Share in Latin America (2020-2021) 9.3 Latin America Cancer Generics Market Size by Country 9.3.1 Latin America Cancer Generics Sales by Country (2016-2021) 9.3.2 Latin America Cancer Generics Market Size Forecast by Country (2022-2027) 9.4 Mexico Market Size Analysis 9.4.1 Mexico Cancer Generics Market Size (2016-2027) 9.4.2 Mexico Cancer Generics Market Size by Type (2016-2027) 9.4.3 Mexico Cancer Generics Market Size by Application (2016-2027) 9.5 Brazil Market Size Analysis 9.5.1 Brazil Cancer Generics Market Size (2016-2027) 9.5.2 Brazil Cancer Generics Market Size by Type (2016-2027) 9.5.3 Brazil Cancer Generics Market Size by Application (2016-2027) 9.6 Argentina Market Size Analysis 9.6.1 Argentina Cancer Generics Market Size (2016-2027) 9.6.2 Argentina Cancer Generics Market Size by Type (2016-2027) 9.6.3 Argentina Cancer Generics Market Size by Application (2016-2027) 10 Middle East & Africa 10.1 Middle East & Africa Cancer Generics Market Size (2016-2027) 10.2 Key Cancer Generics Players Market Share in Middle East & Africa (2020-2021) 10.3 Middle East & Africa Cancer Generics Market Size by Country 10.3.1 Middle East & Africa Cancer Generics Sales by Country (2016-2021) 10.3.2 Middle East & Africa Cancer Generics Market Size Forecast by Country (2022-2027) 10.4 Turkey Market Size Analysis 10.4.1 Turkey Cancer Generics Market Size (2016-2027) 10.4.2 Turkey Cancer Generics Market Size by Type (2016-2027) 10.4.3 Turkey Cancer Generics Market Size by Application (2016-2027) 10.5 Saudi Arabia Market Size Analysis 10.5.1 Saudi Arabia Cancer Generics Market Size (2016-2027) 10.5.2 Saudi Arabia Cancer Generics Market Size by Type (2016-2027) 10.5.3 Saudi Arabia Cancer Generics Market Size by Application (2016-2027) 10.6 UAE Market Size Analysis 10.6.1 UAE Cancer Generics Market Size (2016-2027) 10.6.2 UAE Cancer Generics Market Size by Type (2016-2027) 10.6.3 UAE Cancer Generics Market Size by Application (2016-2027) 11 Key Players Profiles 11.1 Teva Pharmaceuticals 11.1.1 Teva Pharmaceuticals Company Details 11.1.2 Teva Pharmaceuticals Business Overview and Its Total Revenue 11.1.3 Teva Pharmaceuticals Cancer Generics Introduction 11.1.4 Teva Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) 11.1.5 Teva Pharmaceuticals Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview and Its Total Revenue 11.2.3 Pfizer Cancer Generics Introduction 11.2.4 Pfizer Revenue in Cancer Generics Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Accord Healthcare 11.3.1 Accord Healthcare Company Details 11.3.2 Accord Healthcare Business Overview and Its Total Revenue 11.3.3 Accord Healthcare Cancer Generics Introduction 11.3.4 Accord Healthcare Revenue in Cancer Generics Business (2016-2021) 11.3.5 Accord Healthcare Recent Development 11.4 Amneal Pharmaceuticals 11.4.1 Amneal Pharmaceuticals Company Details 11.4.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue 11.4.3 Amneal Pharmaceuticals Cancer Generics Introduction 11.4.4 Amneal Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) 11.4.5 Amneal Pharmaceuticals Recent Development 11.5 Mylan 11.5.1 Mylan Company Details 11.5.2 Mylan Business Overview and Its Total Revenue 11.5.3 Mylan Cancer Generics Introduction 11.5.4 Mylan Revenue in Cancer Generics Business (2016-2021) 11.5.5 Mylan Recent Development 11.6 DrReddy Laboratories 11.6.1 DrReddy Laboratories Company Details 11.6.2 DrReddy Laboratories Business Overview and Its Total Revenue 11.6.3 DrReddy Laboratories Cancer Generics Introduction 11.6.4 DrReddy Laboratories Revenue in Cancer Generics Business (2016-2021) 11.6.5 DrReddy Laboratories Recent Development 11.7 Bedford Pharma 11.7.1 Bedford Pharma Company Details 11.7.2 Bedford Pharma Business Overview and Its Total Revenue 11.7.3 Bedford Pharma Cancer Generics Introduction 11.7.4 Bedford Pharma Revenue in Cancer Generics Business (2016-2021) 11.7.5 Bedford Pharma Recent Development 11.8 Hikma 11.8.1 Hikma Company Details 11.8.2 Hikma Business Overview and Its Total Revenue 11.8.3 Hikma Cancer Generics Introduction 11.8.4 Hikma Revenue in Cancer Generics Business (2016-2021) 11.8.5 Hikma Recent Development 11.9 Cipla 11.9.1 Cipla Company Details 11.9.2 Cipla Business Overview and Its Total Revenue 11.9.3 Cipla Cancer Generics Introduction 11.9.4 Cipla Revenue in Cancer Generics Business (2016-2021) 11.9.5 Cipla Recent Development 11.10 Shilpa Medicare 11.10.1 Shilpa Medicare Company Details 11.10.2 Shilpa Medicare Business Overview and Its Total Revenue 11.10.3 Shilpa Medicare Cancer Generics Introduction 11.10.4 Shilpa Medicare Revenue in Cancer Generics Business (2016-2021) 11.10.5 Shilpa Medicare Recent Development 11.11 Fresenius Kabi 11.11.1 Fresenius Kabi Company Details 11.11.2 Fresenius Kabi Business Overview and Its Total Revenue 11.11.3 Fresenius Kabi Cancer Generics Introduction 11.11.4 Fresenius Kabi Revenue in Cancer Generics Business (2016-2021) 11.11.5 Fresenius Kabi Recent Development 11.12 Zydus Pharmaceuticals 11.12.1 Zydus Pharmaceuticals Company Details 11.12.2 Zydus Pharmaceuticals Business Overview and Its Total Revenue 11.12.3 Zydus Pharmaceuticals Cancer Generics Introduction 11.12.4 Zydus Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) 11.12.5 Zydus Pharmaceuticals Recent Development 11.13 Neopharm 11.13.1 Neopharm Company Details 11.13.2 Neopharm Business Overview and Its Total Revenue 11.13.3 Neopharm Cancer Generics Introduction 11.13.4 Neopharm Revenue in Cancer Generics Business (2016-2021) 11.13.5 Neopharm Recent Development 11.14 Netco 11.14.1 Netco Company Details 11.14.2 Netco Business Overview and Its Total Revenue 11.14.3 Netco Cancer Generics Introduction 11.14.4 Netco Revenue in Cancer Generics Business (2016-2021) 11.14.5 Netco Recent Development 11.15 Mayne Pharma 11.15.1 Mayne Pharma Company Details 11.15.2 Mayne Pharma Business Overview and Its Total Revenue 11.15.3 Mayne Pharma Cancer Generics Introduction 11.15.4 Mayne Pharma Revenue in Cancer Generics Business (2016-2021) 11.15.5 Mayne Pharma Recent Development 11.16 Alvogen 11.16.1 Alvogen Company Details 11.16.2 Alvogen Business Overview and Its Total Revenue 11.16.3 Alvogen Cancer Generics Introduction 11.16.4 Alvogen Revenue in Cancer Generics Business (2016-2021) 11.16.5 Alvogen Recent Development 11.17 Glenmark 11.17.1 Glenmark Company Details 11.17.2 Glenmark Business Overview and Its Total Revenue 11.17.3 Glenmark Cancer Generics Introduction 11.17.4 Glenmark Revenue in Cancer Generics Business (2016-2021) 11.17.5 Glenmark Recent Development 11.18 HBT Labs 11.18.1 HBT Labs Company Details 11.18.2 HBT Labs Business Overview and Its Total Revenue 11.18.3 HBT Labs Cancer Generics Introduction 11.18.4 HBT Labs Revenue in Cancer Generics Business (2016-2021) 11.18.5 HBT Labs Recent Development 11.19 Gland 11.19.1 Gland Company Details 11.19.2 Gland Business Overview and Its Total Revenue 11.19.3 Gland Cancer Generics Introduction 11.19.4 Gland Revenue in Cancer Generics Business (2016-2021) 11.19.5 Gland Recent Development 11.20 Qilu Pharmaceuticals 11.20.1 Qilu Pharmaceuticals Company Details 11.20.2 Qilu Pharmaceuticals Business Overview and Its Total Revenue 11.20.3 Qilu Pharmaceuticals Cancer Generics Introduction 11.20.4 Qilu Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) 11.20.5 Qilu Pharmaceuticals Recent Development 11.21 Akorn Pharmaceuticals 11.21.1 Akorn Pharmaceuticals Company Details 11.21.2 Akorn Pharmaceuticals Business Overview and Its Total Revenue 11.21.3 Akorn Pharmaceuticals Cancer Generics Introduction 11.21.4 Akorn Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) 11.21.5 Akorn Pharmaceuticals Recent Development 11.22 MSN Group 11.22.1 MSN Group Company Details 11.22.2 MSN Group Business Overview and Its Total Revenue 11.22.3 MSN Group Cancer Generics Introduction 11.22.4 MSN Group Revenue in Cancer Generics Business (2016-2021) 11.22.5 MSN Group Recent Development 11.23 Wockhardt 11.23.1 Wockhardt Company Details 11.23.2 Wockhardt Business Overview and Its Total Revenue 11.23.3 Wockhardt Cancer Generics Introduction 11.23.4 Wockhardt Revenue in Cancer Generics Business (2016-2021) 11.23.5 Wockhardt Recent Development 11.24 Rising Pharma 11.24.1 Rising Pharma Company Details 11.24.2 Rising Pharma Business Overview and Its Total Revenue 11.24.3 Rising Pharma Cancer Generics Introduction 11.24.4 Rising Pharma Revenue in Cancer Generics Business (2016-2021) 11.24.5 Rising Pharma Recent Development 11.25 Apotex 11.25.1 Apotex Company Details 11.25.2 Apotex Business Overview and Its Total Revenue 11.25.3 Apotex Cancer Generics Introduction 11.25.4 Apotex Revenue in Cancer Generics Business (2016-2021) 11.25.5 Apotex Recent Development 11.26 Taro Pharmaceuticals 11.26.1 Taro Pharmaceuticals Company Details 11.26.2 Taro Pharmaceuticals Business Overview and Its Total Revenue 11.26.3 Taro Pharmaceuticals Cancer Generics Introduction 11.26.4 Taro Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) 11.26.5 Taro Pharmaceuticals Recent Development 11.27 Sun Pharma 11.27.1 Sun Pharma Company Details 11.27.2 Sun Pharma Business Overview and Its Total Revenue 11.27.3 Sun Pharma Cancer Generics Introduction 11.27.4 Sun Pharma Revenue in Cancer Generics Business (2016-2021) 11.27.5 Sun Pharma Recent Development 11.28 Alkem Laboratories 11.28.1 Alkem Laboratories Company Details 11.28.2 Alkem Laboratories Business Overview and Its Total Revenue 11.28.3 Alkem Laboratories Cancer Generics Introduction 11.28.4 Alkem Laboratories Revenue in Cancer Generics Business (2016-2021) 11.28.5 Alkem Laboratories Recent Development 11.29 Endo Pharma 11.29.1 Endo Pharma Company Details 11.29.2 Endo Pharma Business Overview and Its Total Revenue 11.29.3 Endo Pharma Cancer Generics Introduction 11.29.4 Endo Pharma Revenue in Cancer Generics Business (2016-2021) 11.29.5 Endo Pharma Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer

List of Tables Table 1. Global Cancer Generics Market Size Growth Rate by Type (US$ Million): 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Biological Targeted Therapy Drugs Table 4. Key Players of Prescription Drugs Table 5. Key Players of Chinese Patent Medicine Table 6. Key Players of Other Table 7. Global Cancer Generics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Cancer Generics Market Size by Region (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Cancer Generics Market Size by Regions (2016-2021) (US$ Million) Table 10. Global Cancer Generics Market Share by Regions (2016-2021) Table 11. Global Cancer Generics Forecasted Market Size by Regions (2022-2027) (US$ Million) Table 12. Global Cancer Generics Market Share by Regions (2022-2027) Table 13. Cancer Generics Market Trends Table 14. Cancer Generics Market Drivers Table 15. Cancer Generics Market Challenges Table 16. Cancer Generics Market Restraints Table 17. Ranking of Global Top Cancer Generics Manufacturers by Revenue (US$ Million) in 2020 Table 18. Global Cancer Generics Revenue by Players (2016-2021) (US$ Million) Table 19. Global Cancer Generics Market Share by Players (2016-2021) Table 20. Global Top Cancer Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Generics as of 2020) Table 21. Global 5 Largest Players Market Share by Cancer Generics Revenue (CR5 and HHI) (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Cancer Generics Product Solution and Service Table 24. Date of Enter into Cancer Generics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Cancer Generics Market Size by Type (2016-2021) (US$ Million) Table 27. Global Cancer Generics Revenue Market Share by Type (2016-2021) Table 28. Global Cancer Generics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Cancer Generics Revenue Market Share by Type (2022-2027) Table 30. Global Cancer Generics Market Size by Application (2016-2021) (US$ Million) Table 31. Global Cancer Generics Revenue Market Share by Application (2016-2021) Table 32. Global Cancer Generics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Cancer Generics Revenue Market Share by Application (2022-2027) Table 34. Key Players Cancer Generics Revenue in North America (2020-2021) (US$ Million) Table 35. North America Cancer Generics Market Size by Countries (2016-2021) (US$ Million) Table 36. North America Cancer Generics Market Size Share by Countries (2016-2021) Table 37. North America Cancer Generics Market Size by Countries (2022-2027) (US$ Million) Table 38. North America Cancer Generics Market Size Share by Countries (2022-2027) Table 39. Cancer Generics Market Size (US$ Million) in United States, Breakdown by Type (2016-2021) Table 40. Cancer Generics Market Size (US$ Million) in United States, Breakdown by Type (2022-2027) Table 41. Cancer Generics Market Size (US$ Million) in United States, Breakdown by Application (2016-2021) Table 42. Cancer Generics Market Size (US$ Million) in United States, Breakdown by Application (2022-2027) Table 43. Cancer Generics Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021) Table 44. Cancer Generics Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027) Table 45. Cancer Generics Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021) Table 46. Cancer Generics Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027) Table 47. Key Players Cancer Generics Revenue in Europe (2020-2021) (US$ Million) Table 48. Europe Cancer Generics Market Size by Countries (2016-2021) (US$ Million) Table 49. Europe Cancer Generics Market Size Share by Countries (2016-2021) Table 50. Europe Cancer Generics Market Size by Countries (2022-2027) (US$ Million) Table 51. Europe Cancer Generics Market Size Share by Countries (2022-2027) Table 52. Cancer Generics Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021) Table 53. Cancer Generics Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027) Table 54. Cancer Generics Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021) Table 55. Cancer Generics Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027) Table 56. Cancer Generics Market Size (US$ Million) in France, Breakdown by Type (2016-2021) Table 57. Cancer Generics Market Size (US$ Million) in France, Breakdown by Type (2022-2027) Table 58. Cancer Generics Market Size (US$ Million) in France, Breakdown by Application (2016-2021) Table 59. Cancer Generics Market Size (US$ Million) in France, Breakdown by Application (2022-2027) Table 60. Cancer Generics Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021) Table 61. Cancer Generics Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027) Table 62. Cancer Generics Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021) Table 63. Cancer Generics Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027) Table 64. Cancer Generics Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021) Table 65. Cancer Generics Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027) Table 66. Cancer Generics Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021) Table 67. Cancer Generics Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027) Table 68. Cancer Generics Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021) Table 69. Cancer Generics Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027) Table 70. Cancer Generics Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021) Table 71. Cancer Generics Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027) Table 72. Key Players Cancer Generics Revenue in Asia-Pacific (2020-2021) (US$ Million) Table 73. Asia-Pacific Cancer Generics Market Size by Regions (2016-2021) (US$ Million) Table 74. Asia-Pacific Cancer Generics Market Size by Regions (2022-2027) (US$ Million) Table 75. Cancer Generics Market Size (US$ Million) in China, Breakdown by Type (2016-2021) Table 76. Cancer Generics Market Size (US$ Million) in China, Breakdown by Type (2022-2027) Table 77. Cancer Generics Market Size (US$ Million) in China, Breakdown by Application (2016-2021) Table 78. Cancer Generics Market Size (US$ Million) in China, Breakdown by Application (2022-2027) Table 79. Cancer Generics Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021) Table 80. Cancer Generics Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027) Table 81. Cancer Generics Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021) Table 82. Cancer Generics Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027) Table 83. Cancer Generics Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021) Table 84. Cancer Generics Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027) Table 85. Cancer Generics Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021) Table 86. Cancer Generics Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027) Table 87. Cancer Generics Market Size (US$ Million) in India, Breakdown by Type (2016-2021) Table 88. Cancer Generics Market Size (US$ Million) in India, Breakdown by Type (2022-2027) Table 89. Cancer Generics Market Size (US$ Million) in India, Breakdown by Application (2016-2021) Table 90. Cancer Generics Market Size (US$ Million) in India, Breakdown by Application (2022-2027) Table 91. Cancer Generics Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021) Table 92. Cancer Generics Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027) Table 93. Cancer Generics Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021) Table 94. Cancer Generics Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027) Table 95. Cancer Generics Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021) Table 96. Cancer Generics Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027) Table 97. Cancer Generics Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021) Table 98. Cancer Generics Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027) Table 99. Cancer Generics Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021) Table 100. Cancer Generics Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027) Table 101. Cancer Generics Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021) Table 102. Cancer Generics Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027) Table 103. Key Players Cancer Generics Revenue in Latin America (2020-2021) (US$ Million) Table 104. Latin America Cancer Generics Market Size by Countries (2016-2021) (US$ Million) Table 105. Latin America Cancer Generics Market Size by Countries (2022-2027) (US$ Million) Table 106. Cancer Generics Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021) Table 107. Cancer Generics Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027) Table 108. Cancer Generics Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021) Table 109. Cancer Generics Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027) Table 110. Cancer Generics Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021) Table 111. Cancer Generics Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027) Table 112. Cancer Generics Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021) Table 113. Cancer Generics Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027) Table 114. Cancer Generics Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021) Table 115. Cancer Generics Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027) Table 116. Cancer Generics Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021) Table 117. Cancer Generics Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027) Table 118. Key Players Cancer Generics Revenue in Middle East & Africa (2020-2021) (US$ Million) Table 119. Middle East & Africa Cancer Generics Market Size by Countries (2016-2021) (US$ Million) Table 120. Middle East & Africa Cancer Generics Market Size by Countries (2022-2027) (US$ Million) Table 121. Cancer Generics Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021) Table 122. Cancer Generics Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027) Table 123. Cancer Generics Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021) Table 124. Cancer Generics Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027) Table 125. Cancer Generics Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021) Table 126. Cancer Generics Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027) Table 127. Cancer Generics Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021) Table 128. Cancer Generics Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027) Table 129. Cancer Generics Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021) Table 130. Cancer Generics Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027) Table 131. Cancer Generics Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021) Table 132. Cancer Generics Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027) Table 133. Teva Pharmaceuticals Company Details Table 134. Teva Pharmaceuticals Business Overview Table 135. Teva Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 136. Teva Pharmaceuticals Cancer Generics Cancer Generics Product Table 137. Teva Pharmaceuticals Recent Development Table 138. Pfizer Company Details Table 139. Pfizer Business Overview Table 140. Pfizer Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 141. Pfizer Cancer Generics Product Table 142. Pfizer Recent Development Table 143. Accord Healthcare Company Details Table 144. Accord Healthcare Business Overview Table 145. Accord Healthcare Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 146. Accord Healthcare Cancer Generics Product Table 147. Accord Healthcare Recent Development Table 148. Amneal Pharmaceuticals Company Details Table 149. Amneal Pharmaceuticals Business Overview Table 150. Amneal Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 151. Amneal Pharmaceuticals Cancer Generics Product Table 152. Amneal Pharmaceuticals Recent Development Table 153. Mylan Company Details Table 154. Mylan Business Overview Table 155. Mylan Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 156. Mylan Cancer Generics Product Table 157. Mylan Recent Development Table 158. DrReddy Laboratories Company Details Table 159. DrReddy Laboratories Business Overview Table 160. DrReddy Laboratories Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 161. DrReddy Laboratories Cancer Generics Product Table 162. DrReddy Laboratories Recent Development Table 163. Bedford Pharma Company Details Table 164. Bedford Pharma Business Overview Table 165. Bedford Pharma Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 166. Bedford Pharma Cancer Generics Product Table 167. Bedford Pharma Recent Development Table 168. Hikma Company Details Table 169. Hikma Business Overview Table 170. Hikma Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 171. Hikma Cancer Generics Product Table 172. Hikma Recent Development Table 173. Cipla Company Details Table 174. Cipla Business Overview Table 175. Cipla Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 176. Cipla Cancer Generics Product Table 177. Cipla Recent Development Table 178. Shilpa Medicare Company Details Table 179. Shilpa Medicare Business Overview Table 180. Shilpa Medicare Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 181. Shilpa Medicare Cancer Generics Product Table 182. Shilpa Medicare Recent Development Table 183. Fresenius Kabi Company Details Table 184. Fresenius Kabi Business Overview Table 185. Fresenius Kabi Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 186. Fresenius Kabi Cancer Generics Product Table 187. Fresenius Kabi Recent Development Table 188. Zydus Pharmaceuticals Company Details Table 189. Zydus Pharmaceuticals Business Overview Table 190. Zydus Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 191. Zydus Pharmaceuticals Cancer Generics Product Table 192. Zydus Pharmaceuticals Recent Development Table 193. Neopharm Company Details Table 194. Neopharm Business Overview Table 195. Neopharm Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 196. Neopharm Cancer Generics Product Table 197. Neopharm Recent Development Table 198. Netco Company Details Table 199. Netco Business Overview Table 200. Netco Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 201. Netco Cancer Generics Product Table 202. Netco Recent Development Table 203. Mayne Pharma Company Details Table 204. Mayne Pharma Business Overview Table 205. Mayne Pharma Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 206. Mayne Pharma Cancer Generics Product Table 207. Mayne Pharma Recent Development Table 208. Alvogen Company Details Table 209. Alvogen Business Overview Table 210. Alvogen Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 211. Alvogen Cancer Generics Product Table 212. Alvogen Recent Development Table 213. Glenmark Company Details Table 214. Glenmark Business Overview Table 215. Glenmark Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 216. Glenmark Cancer Generics Product Table 217. Glenmark Recent Development Table 218. HBT Labs Company Details Table 219. HBT Labs Business Overview Table 220. HBT Labs Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 221. HBT Labs Cancer Generics Product Table 222. HBT Labs Recent Development Table 223. Gland Company Details Table 224. Gland Business Overview Table 225. Gland Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 226. Gland Cancer Generics Product Table 227. Gland Recent Development Table 228. Qilu Pharmaceuticals Company Details Table 229. Qilu Pharmaceuticals Business Overview Table 230. Qilu Pharmaceuticals Revenue in Cancer Generics Business (2016-2021) (US$ Million) Table 231. Qilu Pharmaceuticals Cancer Generics Product Table 232. Qilu Pharmaceuticals Recent Development Table 233. Akorn Pharmaceuticals Company Details Table 234. MSN Group Company Details Table 235. Wockhardt Company Details Table 236. Rising Pharma Company Details Table 237. Apotex Company Details Table 238. Taro Pharmaceuticals Company Details Table 239. Sun Pharma Company Details Table 240. Alkem Laboratories Company Details Table 241. Endo Pharma Company Details Table 242. Research Programs/Design for This Report Table 243. Key Data Information from Secondary Sources Table 244. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Generics Market Share by Type: 2020 & 2027 Figure 2. Chemotherapy Features Figure 3. Biological Targeted Therapy Drugs Features Figure 4. Prescription Drugs Features Figure 5. Chinese Patent Medicine Features Figure 6. Other Features Figure 7. Global Cancer Generics Market Share by Application: 2020 & 2027 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Drug Center Case Studies Figure 11. Other Case Studies Figure 12. Cancer Generics Report Years Considered Figure 13. Global Cancer Generics Market Share by Regions: 2016 VS 2021 VS 2027 Figure 14. Global Cancer Generics Market Size YoY Growth 2016-2027 (US$ Million) Figure 15. Global Cancer Generics Market Share by Regions (2022-2027) Figure 16. Global Cancer Generics Market Share by Players in 2020 Figure 17. Global Top Cancer Generics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Generics as of 2020) Figure 18. The Top 10 and 5 Players Market Share by Cancer Generics Revenue in 2020 Figure 19. North America Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 20. United States Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 21. Canada Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 22. Europe Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 23. Germany Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 24. France Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 25. U.K. Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 26. Italy Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 27. Russia Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 28. Asia-Pacific Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 29. China Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 30. Japan Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 31. South Korea Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 32. India Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 33. Australia Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 34. Taiwan Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 35. Indonesia Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 36. Thailand Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 37. Malaysia Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 38. Latin America Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 39. Mexico Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 40. Brazil Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 41. Argentina Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 42. Middle East & Africa Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 43. Turkey Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 44. Saudi Arabia Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 45. UAE Cancer Generics Market Size YoY Growth (2016-2027) (US$ Million) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed

Teva Pharmaceuticals Pfizer Accord Healthcare Amneal Pharmaceuticals Mylan DrReddy Laboratories Bedford Pharma Hikma Cipla Shilpa Medicare Fresenius Kabi Zydus Pharmaceuticals Neopharm Netco Mayne Pharma Alvogen Glenmark HBT Labs Gland Qilu Pharmaceuticals Akorn Pharmaceuticals MSN Group Wockhardt Rising Pharma Apotex Taro Pharmaceuticals Sun Pharma Alkem Laboratories Endo Pharma